IO Biotech Analyst Ratings
BenzingaMar 6 08:19 ET
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and IO Biotech (IOBT)
TipRanksMar 6 07:40 ET
Promising Clinical Trials and Favorable Safety Profile Drives Buy Rating for IO Biotech
TipRanksNov 14, 2023 06:34 ET
IO Biotech (IOBT) Receives a Buy From TD Cowen
TipRanksNov 13, 2023 14:35 ET
Promising Phase 2 Study Results Bolster Buy Rating for IO Biotech: Enhanced Efficacy and Consistent Safety Profile of IO102-IO103 + Pembro Combination Therapy
TipRanksOct 24, 2023 06:17 ET
Piper Sandler Initiates Coverage On IO Biotech With Overweight Rating, Announces Price Target of $10
BenzingaSep 28, 2023 07:17 ET
IO Biotech Analyst Ratings
BenzingaSep 28, 2023 07:16 ET
HC Wainwright & Co. Reiterates Buy on IO Biotech, Maintains $8 Price Target
BenzingaSep 13, 2023 06:31 ET
IO Biotech Analyst Ratings
BenzingaSep 13, 2023 06:30 ET
H.C. Wainwright Remains a Buy on IO Biotech (IOBT)
TipRanksSep 13, 2023 06:26 ET
Morgan Stanley Maintains Overweight on IO Biotech, Lowers Price Target to $7
BenzingaAug 15, 2023 09:00 ET
IO Biotech Analyst Ratings
BenzingaAug 15, 2023 08:59 ET
HC Wainwright & Co. Reiterates Buy on IO Biotech, Lowers Price Target to $8
BenzingaAug 11, 2023 13:12 ET
IO Biotech Analyst Ratings
BenzingaAug 11, 2023 13:11 ET
IO Biotech (IOBT) Gets a Buy From H.C. Wainwright
TipRanksAug 11, 2023 11:45 ET
TD Cowen Reaffirms Their Buy Rating on IO Biotech (IOBT)
TipRanksJun 14, 2023 20:45 ET
IO Biotech (IOBT) Receives a Buy From H.C. Wainwright
TipRanksJun 14, 2023 10:25 ET
Jefferies Reaffirms Their Buy Rating on IO Biotech (IOBT)
TipRanksMay 25, 2023 05:15 ET
H.C. Wainwright Reaffirms Their Buy Rating on IO Biotech (IOBT)
TipRanksMay 12, 2023 10:05 ET
IO Biotech (IOBT) Receives a Buy From H.C. Wainwright
TipRanksMar 15, 2023 06:20 ET
No Data
No Data